NCT05733806Recruiting
Study on Gynecological Rare Cancers
Prospective, Multicenter, Observational Study on Rare Gynecological Cancers
Source: ClinicalTrials.gov · Last updated 23 Feb 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a prospective, observational, multicenter study on gynecological rare tumors.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 8 Feb 2023
- Start date
- 14 Oct 2019
- Primary completion date
- 1 Jan 2025
- Lead sponsor
- National Cancer Institute, Naples
- Diseases
- Childhood cancers
- NCT number
- NCT05733806
What you commit to
- Study type: Observational
- Planned participants: 500
- From 14 Oct 2019 to the primary completion date, 1 Jan 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- -written informed consent not provided
Who the study is looking for
- rare gynecological malignancies
- written informed consent
- patient fit for follow-up
Sex: Female · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ginecologia e Ostetricia, IRCCS Ospedale San Raffaele Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
| IRCCS - Fondazione G. Pascale Coordinator of this site? Confirm its status | Naples | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.